Wellington Management Group’s Clearside Biomedical CLSD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,623
Closed -$114K 1930
2019
Q4
$114K Sell
2,623
-1,634
-38% -$34.3K ﹤0.01% 1994
2019
Q3
$40K Sell
4,257
-13
-0.3% -$186 ﹤0.01% 2012
2019
Q2
$63K Hold
4,270
﹤0.01% 2034
2019
Q1
$88K Sell
4,270
-145,979
-97% -$2.9M ﹤0.01% 2019
2018
Q4
$2.41M Sell
150,249
-142,919
-49% -$6.71M ﹤0.01% 1583
2018
Q3
$27M Buy
293,168
+2,162
+0.7% +$257K 0.01% 984
2018
Q2
$46.7M Sell
291,006
-6,116
-2% -$1.03M 0.01% 818
2018
Q1
$47.8M Buy
297,122
+110,605
+59% +$13.5M 0.01% 794
2017
Q4
$19.6M Sell
186,517
-12,265
-6% -$1.32M ﹤0.01% 1073
2017
Q3
$26.1M Buy
198,782
+6,772
+4% +$827K 0.01% 962
2017
Q2
$26.2M Buy
192,010
+47,696
+33% +$5.73M 0.01% 943
2017
Q1
$17.2M Buy
144,314
+34,694
+32% +$4.1M ﹤0.01% 1086
2016
Q4
$14.7M Sell
109,620
-26,734
-20% -$6.71M ﹤0.01% 1092
2016
Q3
$35.5M Sell
136,354
-2,809
-2% -$344K 0.01% 792
2016
Q2
$14.6M Buy
+139,163
New +$14.6M ﹤0.01% 1047

Other funds holding CLSD

Wellington Management Group's CLSD Position: Q1 2020 in Review

Wellington Management Group sold out of Clearside Biomedical (CLSD) in Q1 2020, closing a stake of 2,623 shares — an estimated $114K sold.

Wellington Management Group first reported a position in CLSD in Q2 2016 and held it in 15 quarters. The position peaked at $47.8M in Q1 2018. 43 funds tracked by Wall St. Rank hold CLSD as of Q1 2020.

  • Wellington Management Group reported no remaining Clearside Biomedical position as of Q1 2020 after selling out during the quarter.
  • Wellington Management Group sold 2,623 Clearside Biomedical shares in Q1 2020, an estimated $114K.
  • Wellington Management Group first reported a position in Clearside Biomedical in Q2 2016 and held it in 15 quarters.
  • Wellington Management Group's Clearside Biomedical position peaked at $47.8M in Q1 2018.
  • 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2020.

Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.